threonine and glucagon-like peptide 1

threonine has been researched along with glucagon-like peptide 1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Faruque, O; Han, X; Lilley, BN; Liu, X; Nie, J; Pan, YA; Sanes, JR; Shi, Y; Zhang, W1
Bosma, T; de Vries, L; de Vries, MP; Kuipers, A; Moll, GN; Rink, R1
Chen, Y; Li, J; Lin, Q; Xia, X; Zhou, Z1

Other Studies

3 other study(ies) available for threonine and glucagon-like peptide 1

ArticleYear
SAD-A potentiates glucose-stimulated insulin secretion as a mediator of glucagon-like peptide 1 response in pancreatic β cells.
    Molecular and cellular biology, 2013, Volume: 33, Issue:13

    Topics: Animals; Calcium; Cell Line; Cyclic AMP; Glucagon-Like Peptide 1; Glucose; Glucose Intolerance; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Pancreas; Phosphorylation; Protein Serine-Threonine Kinases; Threonine

2013
Semi-microbiological synthesis of an active lysinoalanine-bridged analog of glucagon-like-peptide-1.
    Peptides, 2017, Volume: 91

    Topics: Alanine; Amino Acid Sequence; Bacterial Proteins; Glucagon-Like Peptide 1; Hydro-Lyases; Lactococcus lactis; Lysinoalanine; Membrane Proteins; Membrane Transport Proteins; Protein Processing, Post-Translational; SEC Translocation Channels; Serine; Substrate Specificity; Threonine

2017
Site-specific N-terminal PEGylation-based controlled release of biotherapeutics: An application for GLP-1 delivery to improve pharmacokinetics and prolong hypoglycemic effects.
    European journal of medicinal chemistry, 2022, Nov-15, Volume: 242

    Topics: Animals; Delayed-Action Preparations; Glucagon-Like Peptide 1; Hydrazines; Hypoglycemic Agents; Peptides; Polyethylene Glycols; Rats; Threonine

2022